Update from the Spanish Oncology Genitourinary Group on the treatment of advanced renal cell carcinoma: focus on special populations

Cancer Metastasis Reviews
Emiliano CalvoDaniel Castellano

Abstract

Elderly or frail patients are often excluded from clinical trials. As a result, clinical outcome of these patients may differ from those obtained in trials. This situation may also hold true for patients who have severe concomitant diseases such as renal, hepatic, or cardiac dysfunction. Being aware of the wide range of clinical situations that a specialist may face is important to ensure that under any circumstances, the patient will receive the best treatment possible. The Spanish Oncology Genitourinary Group issued its first public statement on recommendations for the optimal management of advanced renal cell carcinoma (RCC). However, some issues remained unsolved. In this report, we discuss the current role of Medical Oncology in the treatment of patients with advanced RCC and review the management of special patient populations, such as elderly or patients with concomitant diseases.

References

Mar 1, 1977·The Journal of Urology·J E MontieD K Montague
Nov 15, 1989·International Journal of Cancer. Journal International Du Cancer·G SchackertI J Fidler
Aug 1, 1993·The Journal of Urology·S G MarcusM M Walther
Oct 5, 2001·Lancet·G H MickischUNKNOWN European Organisation for Research and Treatment of Cancer (EORTC) Genitourinary Group
Nov 3, 2004·Annals of Oncology : Official Journal of the European Society for Medical Oncology·H H HansenUNKNOWN ESMO/ASCO Task Force on Global Curriculum in Medical Oncology
Dec 3, 2004·Journal of the American Society of Nephrology : JASN·Benjamin D HumphreysColm C Magee
Apr 20, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jean-Jacques PatardAllan J Pantuck
May 28, 2005·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·P TherasseUNKNOWN EORTC Soft Tissue and Bone Sarcoma Group
Jan 12, 2007·The New England Journal of Medicine·Robert J MotzerRobert A Figlin
Jun 1, 2007·The New England Journal of Medicine·Gary HudesUNKNOWN Global ARCC Trial
Jun 26, 2007·Annals of Oncology : Official Journal of the European Society for Medical Oncology·E BajettaH Mellstedt
Sep 25, 2007·Transplantation Proceedings·J MoroA Salvador
Dec 19, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Julie GralowUNKNOWN American Society of Clinical Oncology
Jan 1, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Toni K ChoueiriBernard Escudier
Feb 5, 2008·BJU International·Andres J SchraderRainer Hofmann
Apr 4, 2008·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J BellmuntA Berkenblit
Aug 22, 2008·Oncology·Pablo Maroto Rey, Humberto Villavicencio
Oct 8, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Manuela SchmidingerHerwig Schmidinger
Oct 9, 2008·Journal of the National Cancer Institute·Tim EisenUNKNOWN TARGET Study Group
Nov 22, 2008·Journal of Cancer Research and Clinical Oncology·A J SchraderR Hofmann
Mar 4, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Antonius A MillerMark J Ratain
May 1, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C SerrateK Fizazi
May 20, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bernard EscudierRonald M Bukowski
Jun 3, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Robert J MotzerRobert A Figlin
Jul 21, 2009·The Lancet Oncology·Martin E GoreRonald Bukowski
Sep 26, 2009·Journal of Clinical Pharmacology·Reza KhosravanCarlo L Bello
Oct 24, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C MassardB Escudier
Nov 26, 2009·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Javier F CastroagudínEvaristo Varo
Dec 17, 2009·Journal of Cancer Research and Clinical Oncology·Thomas SteinerJan Roigas
Apr 7, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bernard EscudierVesna Sneller

❮ Previous
Next ❯

Citations

Apr 17, 2007·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·Mehmet TurgutFirüzan Kaçar
Nov 15, 2013·Expert Review of Anticancer Therapy·Fable Zustovich, Giacomo Novara
Nov 28, 2014·Clinical Journal of Oncology Nursing·Patricia A Creel

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Annals of Oncology : Official Journal of the European Society for Medical Oncology
S L RicheyN M Tannir
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association
Kenrick Berend, Marcel Levi
Clinical Lymphoma, Myeloma & Leukemia
Agustin AvilésMaría de Jesús Nambo
© 2021 Meta ULC. All rights reserved